Pharma — Juni 2023
-
How Has Merck Stock Performed During The 2022-23 Inflation Shock? https://www.proinvestor.com/investornyt/1002040/how-has-merck-stock-performed-during-the-2022-23-inflation-shock
-
ALK skifter ud på chefkontoret - Peter
Halling skal afløse Carsten Hellmann https://www.proinvestor.com/investornyt/1002827/alk-skifter-ud-pa-chefkontoret-peter-halling-skal-aflose-carsten-hellmann -
ALK-formand om direktørskifte: Bestyrelsen har ønsket smidigt generationsskifte https://www.proinvestor.com/investornyt/1002843/alk-formand-om-direktorskifte-bestyrelsen-har-onsket-smidigt-generationsskifte
-
ALK - Dagens aktie
https://www.proinvestor.com/boards/113278/ -
Analytiker om ALK's direktørskifte: Timingen skaber usikkerhed
https://www.proinvestor.com/investornyt/1002881/analytiker-om-alks-direktorskifte-timingen-skaber-usikkerhed -
Alk-Abello - Direktørfyringen skaber uvished https://www.proinvestor.com/boards/113320
-
FDA Approves Boehringer Ingelheim' Jardiance And Synjardy To Treat Pediatric Type 2 Diabetes
https://www.proinvestor.com/investornyt/1003638/fda-approves-boehringer-ingelheim-jardiance-and-synjardy-to-treat-pediatric-type-2-diabetes -
Pfizer : FDA Approves Talzenna-Xtandi Combination To Treat Prostate Cancer https://www.proinvestor.com/investornyt/1003633/pfizer-fda-approves-talzenna-xtandi-combination-to-treat-prostate-cancer
-
GSK Plc: New Data Shows Vaccine Efficacy Of Arexvy Against RSV-lower Respiratory Tract Disease
https://www.proinvestor.com/investornyt/1003672/gsk-plc-new-data-shows-vaccine-efficacy-of-arexvy-against-rsv-lower-respiratory-tract-disease -
GSK : CDC's Panel Votes To Recommend Arexvy For Prevention Of RSV Disease In Older Adults https://www.proinvestor.com/investornyt/1004230/gsk-cdcs-panel-votes-to-recommend-arexvy-for-prevention-of-rsv-disease-in-older-adults
-
Banksektor presses af europæisk afmatningsfrygt og amerikanske kapitalkrav https://www.proinvestor.com/investornyt/1005028/banksektor-presses-af-europaeisk-afmatningsfrygt-og-amerikanske-kapitalkrav
-
What Will Amgen Buy Next? https://www.proinvestor.com/investornyt/1007916/what-will-amgen-buy-next
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind